NHG-Behandelrichtlijn
1.0
april 2017
april 2017
A. Algemeen

Kernboodschappen

Naar Samenvatting ›

Achtergronden

Naar Samenvatting ›

Epidemiologie

Naar Samenvatting ›

Klinisch beeld

Naar Samenvatting ›

Richtlijnen diagnostiek

Naar Samenvatting ›

Lichamelijk en aanvullend onderzoek

Naar Samenvatting ›

Richtlijnen beleid

Naar Samenvatting ›

Voorlichting en niet-medicamenteuze behandeling

Naar Samenvatting ›

Medicamenteuze behandeling

Naar Samenvatting ›

Volwassenen

Naar Samenvatting ›

Controle en verwijzing

Naar Samenvatting ›

Referenties

  1. NIVEL. Incidentie- en prevalentiecijfers van gezondheidsproblemen in de Nederlandse huisartsenpraktijk in 2014 (2016). Ga naar bron: NIVEL. Incidentie- en prevalentiecijfers van gezondheidsproblemen in de Nederlandse huisartsenpraktijk in 2014 (2016).
  2. Murdin L, Golding J, Bronstein A. Managing motion sickness. BMJ 2011;343:d7430.
  3. Golding JF. Motion sickness susceptibility. Auton Neurosci 2006;129:67-76.
  4. Bos JE, MacKinnon SN, Patterson A. Motion sickness symptoms in a ship motion simulator: effects of inside, outside, and no view. Aviat Space Environ Med 2005;76:1111-8.
  5. Yen Pik Sang F, Billar J, Gresty MA, Golding JF. Effect of a novel motion desensitization training regime and controlled breathing on habituation to motion sickness. Percept Mot Skills 2005;101:244-56.
  6. Turner M, Griffin MJ. Motion sickness in public road transport: the effect of driver, route and vehicle. Ergonomics 1999;42:1646-64.
  7. Huppert D, Oldelehr H, Krammling B, Benson J, Brandt T. What the ancient greeks and romans knew (and did not know) about seasickness. Neurology 2016;86:560-5.
  8. Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA. Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. J Travel Med 2003b;10:108-11.
  9. Yen Pik Sang FD, Golding JF, Gresty MA. Suppression of sickness by controlled breathing during mildly nauseogenic motion. Aviat Space Environ Med 2003a;74:998-1002.
  10. Stromberg SE, Russell ME, Carlson CR. Diaphragmatic breathing and its effectiveness for the management of motion sickness. Aerosp Med Hum Perform 2015;86:452-7.
  11. Keshavarz B, Hecht H. Pleasant music as a countermeasure against visually induced motion sickness. Appl Ergon 2014;45:521-7.
  12. Keshavarz B, Stelzmann D, Paillard A, Hecht H. Visually induced motion sickness can be alleviated by pleasant odors. Exp Brain Res 2015;233:1353-64.
  13. Bos JE. Less sickness with more motion and/or mental distraction. J Vestib Res 2015;25:23-33.
  14. Brand JJ, Colquhoun WP, Gould AH, Perry WL. (--)-Hyoscine and cyclizine as motion sickness remedies. Br J Pharmacol Chemother 1967;30:463-9.
  15. Hargreaves J. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness. Practitioner 1980;224:547-50.
  16. Doweck I, Gordon CR, Spitzer O, Melamed Y, Shupak A. Effect of cinnarizine in the prevention of seasickness. Aviat Space Environ Med 1994;65:606-9.
  17. Shupak A, Doweck I, Gordon CR, Spitzer O. Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study. Clin Pharmacol Ther 1994;55:670-80.
  18. Lyon RF, Rush SC, Roland JT Jr, Jethanamest D, Schwan CP, Kharon CU. Cinnarizine for sea sickness during a remote pacific ocean rescue mission. J Spec Oper Med 2015;15:1-6.
  19. Dahl E, Offer-Ohlsen D, Lillevold PE, Sandvik L. Transdermal scopolamine, oral meclizine, and placebo in motion sickness. Clin Pharmacol Ther 1984;36:116-20.
  20. Wood CD, Kennedy RE, Graybiel A, Trumbull R, Wherry RJ. Clinical effectiveness of anti-motion-sickness drugs. Computer review of the literature. JAMA 1966;198:1155-8.
  21. Wood CD, Graybiel A. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Aerosp Med 1968;39:1341-4.
  22. Cowings PS, Toscano WB, DeRoshia C, Miller NE. Promethazine as a motion sickness treatment: impact on human performance and mood states. Aviat Space Environ Med 2000;71:1013-22.
  23. Schmid R, Schick T, Steffen R, Tschopp A, Wilk T. Comparison of seven commonly used agents for prophylaxis of seasickness. J Travel Med 1994;1:203-6.
  24. Cheung BS, Heskin R, Hofer KD. Failure of cetirizine and fexofenadine to prevent motion sickness. Ann Pharmacother 2003;37:173-7.
  25. Spinks A, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 2011:CD002851.
  26. Gil A, Nachum Z, Tal D, Shupak A. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study. Clin Neuropharmacol 2012;35:37-9.
  27. Zorginstituut. Scopolamine (2016). Ga naar bron: Zorginstituut. Scopolamine (2016).
  28. Grontved A, Brask T, Kambskard J, Hentzer E. Ginger root against seasickness. a controlled trial on the open sea. Acta Otolaryngol 1988;105:45-9.
  29. Lien HC, Sun WM, Chen YH, Kim H, Hasler W, Owyang C. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003;284:G481-9.
  30. Holtmann S, Clarke AH, Scherer H, Höhn M. The anti-motion sickness mechanism of ginger. A comparative study with placebo and dimenhydrinate. Acta Otolaryngol 1989;108:168-74.
De Jong J, Verduijn MM
3 gerelateerde lacunes